Lincoln Pharmaceuticals Ltd (Lincoln) manufactures and trades pharmaceutical products, including medicines, injections, and related chemical and botanical products. The company has a product portfolio of over 1,700 registered products and an additional 700 in the pipeline. It specializes in more than 15 therapeutic areas, including anti-infectives, respiratory, gynecology, cardiology, central nervous system (CNS), anti-diabetic and anti-malarial treatments.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lincoln has developed over 600 formulations across 15 therapeutic areas, with a strong portfolio in anti-infectives, respiratory, gynecology, cardiology, central nervous system, anti-diabetic, anti-malarial, and more. Its R&D team includes over 75 professionals, with 30 scientists dedicated to advancing new active substances, generics, and patent non-infringing products tailored for both emerging and domestic markets. Lincoln has filed over 25 patent applications and holds 7 patents to date. It is recognized for pioneering several first-to-market formulations in India, such as the Anti-Fungal Vaginal Spray, Diclofenac Rectal Spray, Sildenafil Oral Spray and Ondansetron Hydrochloride Oral Spray (DOMI-UP).